Endo Health
Solutions ENDP today announced that its wholly owned subsidiary,
HealthTronics, Inc. has entered into a definitive agreement to sell its
anatomical pathology business, HealthTronics Laboratory Solutions, Inc.,
("HLS") to Metamark Genetics, Inc. ("Metamark") for an undisclosed amount.
As previously announced Endo Health Solutions is pursuing strategic
alternatives for HealthTronics, Inc. and believes the sale of HLS creates
progress in this process.
Metamark is at the leading edge of research in cancer prognosis, which is a
critical tool in determining appropriate cancer therapy. In the age of
personalized medicine, particularly in oncology, Metamark's proprietary
multiplex proteomic platform has the potential to reshape the landscape in
cancer diagnosis and therapy.
HLS provides anatomical pathology services primarily to the urology community.
The HLS pathology labs are located in Georgia and Pennsylvania and provide
laboratory and diagnostic services to urologists throughout the U.S., with
client practices in 41 states. In addition, HLS manages pathology
laboratories for physician practice groups, provides administrative services
to in-office pathology labs for practice groups, and provides pathology
services to physicians.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in